您正在使用较旧版本的浏览器。为了获得最佳 MSN 中文网体验,请使用受支持的版本

Cost of rapid COVID-19 testing to be halved in low- and middle-income countries: Unitaid

N.C.N. Limited 徽标 N.C.N. Limited 2021/1/22 ,
a group of people standing in front of a building © Provided by N.C.N. Limited

People wait to enter a COVID-19 test station in Munich, Germany, on Jan. 15, 2021. (Photo by Philippe Ruiz/Xinhua)

In a media statement released Friday, Unitaid and FIND also declared that they will increase capacity to produce "264 million test kits" during "the coming 12 months."

The move will bring the price of these tests from five U.S. dollars to 2.5 each, as well as increase supply of those tests for LMICs.

GENEVA, Jan. 22 (Xinhua) -- Unitaid, a global health initiative that works with partners to bring about innovations to prevent, diagnose and treat major diseases in low- and middle-income countries (LMICs), and the Foundation for Innovative New Diagnostics (FIND) on Friday announced that they have finalized an agreement to cut in half the costs of antigen-detecting rapid diagnostic tests.

In a media statement released Friday, Unitaid and FIND also declared that they will increase capacity to produce "264 million test kits" during "the coming 12 months."

The announcement said that the move will bring the price of these tests from five U.S. dollars to 2.5 each, as well as increase supply of those tests for LMICs.

a man talking on a cell phone © Provided by N.C.N. Limited

A medical worker tests a patient at a hospital in Barcelona, Spain, March 20, 2020. (Photo by Francisco Avia/Xinhua)

Describing the move as an important step towards ensuring equitable access to antigen-detecting rapid diagnostic tests for COVID-19, Unitaid spokesman Herve Verhoosel said this initial agreement will increase capacity on the part of the companies involved to supply such tests.

The availability of these tests will be sufficient to meet approximately 50 percent of the total estimated antigen testing needs of LMICs, he said.

According to Verhoosel, testing has played a critical role since the beginning of the COVID-19 pandemic, enabling patient care as well as providing decision-makers with vital data to inform test-trace-isolate strategies and lockdowns.

While high-income countries are now conducting 252 tests per 100,000 people each day, in LMICs the rate is 90 percent lower, at just 24 tests per 100,000 people, he said. 

© Provided by N.C.N. Limited

Italian Army soldiers work to build a Rapid Antigen Test spot outside the Juventus' Allianz Stadium in Turin, Italy, Nov. 12, 2020. (Photo by Federico Tardito/Xinhua)

image beaconimage beaconimage beacon